Skip to main content

Table 1 Demographic and baseline characteristics, ITT and ITT-VP population

From: Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial

 

ITT

ITT-VP

 

Carrageenan

Placebo

 

Carrageenan

Placebo

 
 

n

%

n

%

p value

n

%

n

%

p value

Gender

          

Male

51

50.0%

42

41.6%

 

29

49.2%

24

40.7%

 

Female

51

50.0%

59

58.4%

0.23*

30

50.8%

35

59.3%

0.36*

 

Mean

SD

Mean

SD

 

Mean

SD

Mean

SD

 

Age, years

33.7

12.9

33.3

12.9

0.84**

31.6

12.0

32.6

12.9

0.65**

Weight, kg

74.0

15.4

73.8

15.7

0.95**

71.5

13.1

70.1

13.8

0.56**

Height, cm

174.0

10.4

173.2

9.4

0.55**

174.3

10.1

172.8

9.9

0.86**

 

n

%

n

%

 

n

%

n

%

 

Smoking status

          

Active smoker

36

35.3%

32

31.7%

0.59*

24

40.7%

17

28.8%

0.18*

Passive smoker

25

24.5%

22

21.8%

0.65*

17

28.8%

13

22.0%

0.40*

Active OR passive smoker

44

43.1%

40

39.6%

0.61*

30

50.8%

21

35.6%

0.09*

 

Mean

SD

Mean

SD

 

Mean

SD

Mean

SD

 

Baseline TSS

6.3

2.0

6.4

1.9

0.56**

6.3

2.0

6.4

1.7

0.77**

  1. *Chi-square test.
  2. **t-test.